SWITZERLAND – Novartis has agreed to pay up to US$1.5 billion for Gyroscope Therapeutics, a U.K.-based ocular gene therapy company, as the pharmaceutical giant seeks to acquire smaller companies with…
Read MoreNovartis buys ocular gene therapy firm for US$1.5 billion
